Prospective study of hepatitis B virus reactivation in patients with hematological malignancies

Prospective observational study evaluating the association of 124 polymorphisms with the response to adalimumab or infliximab (PASI75) in patients with moderate-to-severe

Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in

Construction of live vaccines using genetically engineered poxviruses: Biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the

La detección del virus de la hepatitis C oculto en nuestras muestras de pacientes con nefropatía glomerular y diabética, así como en trasplantados renales anti-VHC negativo,

The duration of the antiviral therapy could compromise the validation of the questionnaire if there were differences between the mean duration treatment, classified according to

The aim of our study was to evaluate the association between excess weight and cancer immunotherapy outcome and toxicity in patients with advanced solid and hematological tumors

The aim of this work is to search for immunological genetic markers that can explain the natural evolution of hepatitis C virus infection in the patient coinfected with the